Published in PLoS One on December 20, 2011
Parallel basal ganglia circuits for voluntary and automatic behaviour to reach rewards. Brain (2015) 1.01
Barriers to exercise in people with Parkinson disease. Phys Ther (2013) 0.98
Effects of orthostatic hypotension on cognition in Parkinson disease. Neurology (2016) 0.88
What is measured with verbal fluency tests in Parkinson's disease patients at different stages of the disease? J Neural Transm (Vienna) (2012) 0.80
Changes in Timing and kinematics of goal directed eye-hand movements in early-stage Parkinson's disease. Transl Neurodegener (2013) 0.77
Task-rest modulation of basal ganglia connectivity in mild to moderate Parkinson's disease. Brain Imaging Behav (2015) 0.77
The epidemiology and clinical manifestations of dysexecutive syndrome in Parkinson's disease. Front Neurol (2012) 0.76
"Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res (1975) 301.74
Parkinsonism: onset, progression and mortality. Neurology (1967) 36.06
Deficits in strategy application following frontal lobe damage in man. Brain (1991) 4.66
Severe disturbance of higher cognition after bilateral frontal lobe ablation: patient EVR. Neurology (1985) 3.88
Cognitive profile of patients with newly diagnosed Parkinson disease. Neurology (2005) 3.29
The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort. Brain (2009) 3.03
The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN study. Brain (2003) 2.81
Cognitive deficits in Parkinson's disease. J Neurol (1997) 2.49
Neural bases of set-shifting deficits in Parkinson's disease. J Neurosci (2004) 1.94
Quality of life in Parkinson's disease: the relative importance of the symptoms. Mov Disord (2008) 1.92
The "posture second" strategy: a review of wrong priorities in Parkinson's disease. J Neurol Sci (2006) 1.78
Mechanisms of cognitive set flexibility in Parkinson's disease. Brain (2001) 1.71
The effect of Parkinson's disease on the ability to maintain a mental set. J Neurol Neurosurg Psychiatry (1985) 1.59
The rate of cognitive decline in Parkinson disease. Arch Neurol (2004) 1.44
Dual task performance and processing resources in normal subjects and patients with Parkinson's disease. Brain (1991) 1.40
Cognitive decline in Parkinson's disease: a prospective longitudinal study. J Int Neuropsychol Soc (2009) 1.31
Course of cognitive decline in Parkinson's disease: a meta-analysis. J Int Neuropsychol Soc (2007) 1.24
Neural correlates of dual task performance in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry (2007) 1.22
Normative data for the Animal, Profession and Letter M Naming verbal fluency tests for Dutch speaking participants and the effects of age, education, and sex. J Int Neuropsychol Soc (2006) 1.18
The assessment of executive functions: coming out of the office. Brain Inj (2004) 1.14
[Letter fluency: psychometric properties and Dutch normative data]. Tijdschr Gerontol Geriatr (2008) 1.04
Reduction in external cues and movement sequencing in Parkinson's disease. J Neurol Neurosurg Psychiatry (1994) 1.03
Unilateral pallidotomy versus bilateral subthalamic nucleus stimulation in PD: a randomized trial. Neurology (2004) 1.01
Skilled hand dexterity in Parkinson's disease: effects of adding a concurrent task. Arch Phys Med Rehabil (2010) 1.00
Dimensions of executive function in Parkinson's disease. Dement Geriatr Cogn Disord (2005) 0.97
Striatal FDOPA uptake and cognition in advanced non-demented Parkinson's disease: a clinical and FDOPA-PET study. Parkinsonism Relat Disord (2008) 0.89
Creativity in Parkinson's disease as a function of right versus left hemibody onset. J Neurol Sci (2008) 0.88
Behavioural assessment of dysexecutive syndrome in Parkinson's disease without dementia: a comparison with other clinical executive tasks. Parkinsonism Relat Disord (2009) 0.85
Differentiation of parkinsonian syndromes according to differences in executive functions. J Neural Transm (Vienna) (2003) 0.84
Researching a differential impairment of frontal functions and explicit memory in early Parkinson's disease. Eur J Neurol (2000) 0.82
Putamen FDOPA uptake and its relationship tot cognitive functioning in PD. J Neurol Sci (2006) 0.81
Impaired self-initiated task preparation during task switching in Parkinson's disease. Neuropsychologia (2006) 0.80
Complaints about impairments in executive functions in Parkinson's disease: the association with neuropsychological assessment. Parkinsonism Relat Disord (2011) 0.79
The effects of two different auditory stimuli on functional arm movement in persons with Parkinson's disease: a dual-task paradigm. Clin Rehabil (2009) 0.79
Measuring the executive functions in schizophrenia: the voluntary allocation of effort. J Psychiatr Res (2005) 0.79
Planning and task management in Parkinson's disease: differential emphasis in dual-task performance. J Int Neuropsychol Soc (2008) 0.79
Subjective and objective assessment of executive functions in Parkinson's disease. J Neurol Sci (2011) 0.77
Normative data for two neuropsychological tests sensitive to frontal dysfunction. Ital J Neurol Sci (1996) 0.77
Blood-brain barrier dysfunction in parkinsonian midbrain in vivo. Ann Neurol (2005) 2.54
Gender differences in Parkinson's disease. J Neurol Neurosurg Psychiatry (2006) 2.23
No disease in the brain of a 115-year-old woman. Neurobiol Aging (2008) 1.97
Handedness correlates with the dominant Parkinson side: a systematic review and meta-analysis. Mov Disord (2011) 1.84
Echogenicity of the substantia nigra: association with increased iron content and marker for susceptibility to nigrostriatal injury. Arch Neurol (2002) 1.45
The effect of visual field defects on driving performance: a driving simulator study. Arch Ophthalmol (2002) 1.44
Blood-brain barrier P-glycoprotein function decreases in specific brain regions with aging: a possible role in progressive neurodegeneration. Neurobiol Aging (2008) 1.30
Chorein detection for the diagnosis of chorea-acanthocytosis. Ann Neurol (2004) 1.28
Typical cerebral metabolic patterns in neurodegenerative brain diseases. Mov Disord (2010) 1.22
The history of attention deficit hyperactivity disorder. Atten Defic Hyperact Disord (2010) 1.16
Impaired visual processing preceding image recognition in Parkinson's disease patients with visual hallucinations. Brain (2009) 1.15
Predicting practical fitness to drive in drivers with visual field defects caused by ocular pathology. Hum Factors (2004) 1.14
Pergolide versus levodopa monotherapy in early Parkinson's disease patients: The PELMOPET study. Mov Disord (2006) 1.09
Executive functions in children with dyslexia. Dyslexia (2005) 1.07
Validation of parkinsonian disease-related metabolic brain patterns. Mov Disord (2013) 1.06
Neuroinflammation in the pathophysiology of Parkinson's disease: evidence from animal models to human in vivo studies with [11C]-PK11195 PET. Mov Disord (2007) 1.05
Brain imaging in patients with freezing of gait. Mov Disord (2008) 1.04
Effects of a multifaceted treatment program for executive dysfunction after acquired brain injury on indications of executive functioning in daily life. J Int Neuropsychol Soc (2009) 1.00
Risky behavior in gambling tasks in individuals with ADHD--a systematic literature review. PLoS One (2013) 1.00
Striatal dopa and glucose metabolism in PD patients with freezing of gait. Mov Disord (2006) 0.99
Simultaneous EMG-functional MRI recordings can directly relate hyperkinetic movements to brain activity. Hum Brain Mapp (2008) 0.99
Differences between participants and non-participants in an RCT on physical activity and psychological interventions for older persons. Aging Clin Exp Res (2005) 0.99
Late-onset Huntington disease with intermediate CAG repeats: true or false? J Neurol Neurosurg Psychiatry (2010) 0.99
Vigilance and sustained attention in children and adults with ADHD. J Atten Disord (2008) 0.99
Parkinson's disease: the syndrome, the pathogenesis and pathophysiology. Cortex (2008) 0.98
Visuospatial asymmetry and non-spatial attention in subacute stroke patients with and without neglect. Cortex (2009) 0.97
Genetics of early-onset obsessive-compulsive disorder. Eur Child Adolesc Psychiatry (2010) 0.97
Metabolic network as a progression biomarker of premanifest Huntington's disease. J Clin Invest (2013) 0.95
The impact of executive functions on verb production in patients with Parkinson's disease. Cortex (2009) 0.93
Changed patterns of cerebral activation related to clinically normal hand movement in cervical dystonia. Clin Neurol Neurosurg (2007) 0.92
The Introduction of Bioptic Driving in The Netherlands. Vis Impair Res (2008) 0.92
Cerebral activation during motor imagery in complex regional pain syndrome type 1 with dystonia. Pain (2007) 0.92
Echogenicity of the substantia nigra in relatives of patients with sporadic Parkinson's disease. Neuroimage (2003) 0.90
Striatal FDOPA uptake and cognition in advanced non-demented Parkinson's disease: a clinical and FDOPA-PET study. Parkinsonism Relat Disord (2008) 0.89
Brain dopamine and kinematics of graphomotor functions. Hum Mov Sci (2006) 0.89
The effect of visual field defects on eye movements and practical fitness to drive. Vision Res (2002) 0.89
Animal models of attention deficit/hyperactivity disorder (ADHD): a critical review. Atten Defic Hyperact Disord (2010) 0.89
Neural networks of response shifting: influence of task speed and stimulus material. Brain Res (2006) 0.89
Language and Parkinson's disease. Cortex (2009) 0.88
Cyclooxygenase and neuroinflammation in Parkinson's disease neurodegeneration. Curr Neuropharmacol (2010) 0.88
Cerebral activation patterns related to initiation and inhibition of hand movement. Neuroreport (2007) 0.88
Cognitive, physiological, and personality correlates of recurrence of depression. J Affect Disord (2005) 0.88
Age-related changes in event-related prospective memory performance: a comparison of four prospective memory tasks. Brain Cogn (2002) 0.88
Biomarkers for attention-deficit/hyperactivity disorder (ADHD). A consensus report of the WFSBP task force on biological markers and the World Federation of ADHD. World J Biol Psychiatry (2012) 0.87
Walking trajectory in neglect patients. Gait Posture (2006) 0.87
Simulated driving in obstructive sleep apnoea-hypopnoea; effects of oral appliances and continuous positive airway pressure. Sleep Breath (2007) 0.87
Functional recovery of gait and joint kinematics after right hemispheric stroke. Arch Phys Med Rehabil (2004) 0.87
Is moderate substance use associated with altered executive functioning in a population-based sample of young adults? Hum Psychopharmacol (2009) 0.87
Abnormal parietal function in conversion paresis. PLoS One (2011) 0.87
TCH346 prevents motor symptoms and loss of striatal FDOPA uptake in bilaterally MPTP-treated primates. Neurobiol Dis (2003) 0.86
Measurement of stigmatization towards adults with attention deficit hyperactivity disorder. PLoS One (2012) 0.86
1H magnetic resonance spectroscopy in preclinical Huntington disease. Brain Res (2007) 0.86
MDR1 variants and risk of Parkinson disease. Association with pesticide exposure? J Neurol (2009) 0.85
Handedness and dominant side of symptoms in Parkinson's disease. Parkinsonism Relat Disord (2010) 0.85
Striatal dopaminergic activity (FDOPA-PET) associated with cognitive items of a depression scale (MADRS) in Parkinson's disease. Eur J Neurosci (2007) 0.84
Physical predictors of cognitive performance in healthy older adults: a cross-sectional analysis. PLoS One (2013) 0.84
Direct comparison between regional cerebral metabolism in progressive supranuclear palsy and Parkinson's disease. Mov Disord (2005) 0.84
Cognitive dysfunction in non-demented Parkinson's disease patients: controlled and automatic behavior. Cortex (2009) 0.84
Is levodopa toxic? J Neurol (2004) 0.84
Coping strategies and IQ in psychogenic movement disorders and paralysis. Mov Disord (2009) 0.83
Differential effects of methylphenidate on problem solving in adults with ADHD. J Atten Disord (2010) 0.83
Age-related changes in the functional visual field: further evidence for an inverse Age x Eccentricity effect. J Gerontol B Psychol Sci Soc Sci (2004) 0.83
Time estimation in Parkinson's disease and degenerative cerebellar disease. Neuroreport (2008) 0.82
Cognitive functioning in patients treated for nonfunctioning pituitary macroadenoma and the effects of pituitary radiotherapy. Clin Endocrinol (Oxf) (2011) 0.82
Circadian rhythms in obsessive-compulsive disorder. J Neural Transm (Vienna) (2012) 0.82
Visuospatial asymmetry in dual-task performance after subacute stroke. J Neuropsychol (2012) 0.82
Breakpoint mapping of 13 large parkin deletions/duplications reveals an exon 4 deletion and an exon 7 duplication as founder mutations. Neurogenetics (2011) 0.82
The influence of cognitive reserve on cognition in Parkinson's disease. J Neural Transm (Vienna) (2012) 0.82
Neuropsychological and emotional correlates of personality traits in Parkinson's disease. Behav Neurol (2013) 0.81
Detrimental effects of gum chewing on vigilance in children with attention deficit hyperactivity disorder. Appetite (2010) 0.81
Complex prospective memory in adults with attention deficit hyperactivity disorder. PLoS One (2013) 0.81
Differences in the EMG pattern of leg muscle activation during locomotion in Parkinson's disease. Funct Neurol (2004) 0.81
Putamen FDOPA uptake and its relationship tot cognitive functioning in PD. J Neurol Sci (2006) 0.81
Difficulties in Daily Life Reported by Patients With Homonymous Visual Field Defects. J Neuroophthalmol (2015) 0.81
Processing of continuously provided punishment and reward in children with ADHD and the modulating effects of stimulant medication: an ERP study. PLoS One (2013) 0.81
Prefrontal cortex and striatal activation by feedback in Parkinson's disease. Brain Res (2008) 0.81
Benign childhood epilepsy with centrotemporal spikes and the multicomponent model of attention: a matched control study. Epilepsy Behav (2010) 0.81
Attention impairment in childhood absence epilepsy: an impulsivity problem? Epilepsy Behav (2013) 0.80
Changes in cerebral activations during movement execution and imagery after parietal cortex TMS interleaved with 3T MRI. Brain Res (2009) 0.80
What is measured with verbal fluency tests in Parkinson's disease patients at different stages of the disease? J Neural Transm (Vienna) (2012) 0.80
[Children and adolescents with obsessive-compulsive disorders]. Z Kinder Jugendpsychiatr Psychother (2009) 0.80
Whole-body vibration improves cognitive functions of an adult with ADHD. Atten Defic Hyperact Disord (2014) 0.80
Spatial memory in spontaneously hypertensive rats (SHR). PLoS One (2013) 0.80
Complaints about impairments in executive functions in Parkinson's disease: the association with neuropsychological assessment. Parkinsonism Relat Disord (2011) 0.79
Cerebral activations related to ballistic, stepwise interrupted and gradually modulated movements in Parkinson patients. PLoS One (2012) 0.79
Narrowing wide-field optic flow affects treadmill gait in left-sided Parkinson's disease. Mov Disord (2011) 0.79
Psychological and physical activity training for older persons: who does not attend? Gerontology (2006) 0.79
Is FDG-PET a useful tool in clinical practice for diagnosing corticobasal ganglionic degeneration? Mov Disord (2003) 0.79
Effect of ageing on the ability to adapt to a visual distortion during walking. Gait Posture (2005) 0.79
Striatal metabolism and psychomotor speed as predictors of motor onset in Huntington's disease. J Neurol (2014) 0.78
Quantifying interhemispheric symmetry of somatosensory evoked potentials with the intraclass correlation coefficient. J Clin Neurophysiol (2008) 0.78
Effects of previous growth hormone excess and current medical treatment for acromegaly on cognition. Eur J Clin Invest (2012) 0.78
Coherence analysis differentiates between cortical myoclonic tremor and essential tremor. Mov Disord (2006) 0.78
Effects of DSP4 and methylphenidate on spatial memory performance in rats. Atten Defic Hyperact Disord (2011) 0.78
In vivo binding behavior of dopamine receptor agonist (+)-PD 128907 and implications for the "ceiling effect" in endogenous competition studies with [(11)C]raclopride-a positron emission tomography study in Macaca mulatta. J Cereb Blood Flow Metab (2004) 0.78